Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer Research

• Publication date

  1994-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 7522956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents

  1994cited by this paper
• Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).

  1993cited by this paper
• Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution.

  1993cited by this paper
• Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo.

  1993cited by this paper
• Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.

  1993cited by this paper
• Basic fibroblast growth factor in human prostate cancer cells.

  1992cited by this paper
• Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.

  1992cited by this paper
• Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.

  1992cited by this paper
• A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine.

  1992cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Regulators of angiogenesis.

  1991cited by this paper
• Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor.

  1991cited by this paper
• Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.

  1991cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

  1990cited by this paper
• Systemic treatment of a human epidermoid non-small cell lung carcinoma xenograft with a xanthate compound causes extensive intratumoral necrosis.

  1990cited by this paper
• Antitumor effect of GPA1734 in rat Walker 256 carcinoma

  1990cited by this paper
• Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

  1990cited by this paper
• Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture.

  1989cited by this paper
• Induction of angiogenesis during the transition from hyperplasia to neoplasia

  1989cited by this paper
• Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid.

  1989cited by this paper
• Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.

  1988cited by this paper
• Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses

  1988cited by this paper
• Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate.

  1987cited by this paper
• Inhibition of vascular endothelial cell growth and trypsin activity by vitreous.

  1985cited by this paper
• Inhibition of tumour‐induced angiogenesis by systemically administered protamine sulphate

  1984cited by this paper
• Effect of medroxyprogesterone and an aorta-derived cell growth inhibitor on B16 melanoma in mice.

  1984cited by this paper
• Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

  1983cited by this paper
• Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer.

  1982cited by this paper
• Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone.

  1981cited by this paper
• The significance of atypical vessels and neovascularization in cervical neoplasia.

  1981cited by this paper
• Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder

  1980cited by this paper
• Control of tumor growth in animals by infusion of an angiogenesis inhibitor.

  1980cited by this paper
• Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.

  1974cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper
• The treatment of amebiasis with fumagillin.

  1952cited by this paper

• Expanding the immunotherapy universe in extensive-stage small cell lung cancer: from chemoimmunotherapy backbone to next-wave combinations

  2025cites this paper
• Evaluation of Depressive and Anxious Behavior with the Use of Propranolol in Melanoma-Bearing Mice

  2021cites this paper
• Biologically active Camellia oleifera protein nanoparticles for improving the tumor microenvironment and drug delivery.

  2020cites this paper
• Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.

  2019cites this paper
• Synergistic combination of YS-1 and adriamycin inhibits human renal cancer through ERK1/2 signaling pathway in vitro and in vivo.

  2017cites this paper
• Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery

  2016cites this paper
• A Review on Herbal Plants with Anti-Tumour Properties

  2014cites this paper
• Antiangiogenic and finasteride therapies: responses of the prostate microenvironment in elderly mice.

  2014influential citation
• Therapeutic targeting of tumor angiogenesis: how far have we come?

  2014cites this paper
• The Effect of the Serum Amino Acid Levels Thiosemicarbazone Derivatives and its Metal Complexes on Rats

  2013cites this paper
• Evaluation of Antitumor Activity of Bark Extract of Magnolia grandiflora Linn. in vivo and in vitro

  2012cites this paper
• In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy

  2012cites this paper
• In vivo peritoneal antiangiogenesis and in vitro antiproliferative properties of some bischalcone derivatives

  2012cites this paper
• Immunomodulatory effect of polysaccharides from submerged cultured Cordyceps gunnii

  2012influential citation
• Formosanin C-inhibited pulmonary metastasis through repression of matrix metalloproteinases on mouse lung adenocarcinoma

  2011cites this paper
• Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model.

  2011cites this paper
• Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis.

  2011cites this paper
• Synthesis and in vivo anticancer and antiangiogenic effects of novel thioxothiazolidin-4-one derivatives against transplantable mouse tumor

  2010cites this paper
• Prostate-Specific Antigen

  2010cites this paper
• Synthesis, Characterization and Anti-Angiogenic Effects of Novel 5-Amino Pyrazole Derivatives on Ehrlich Ascites Tumor [EAT] Cells in-Vivo

  2010cites this paper
• Non-Peptidic Mimetics as Cancer-Sensitizing Agents

  2008cites this paper
• TNP-470: The Resurrection of the First Synthetic Angiogenesis Inhibitor

  2008cites this paper
• Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.

  2008cites this paper
• Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of tumor growth and tumor angiogenesis of mouse ehrlich ascites tumor in vivo.

  2008cites this paper
• Anti-tumor effect of angiogenesis inhibitor TNP-470 and 5-FU combined therapy on human gastric cancer xenograft.

  2008cites this paper
• Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization.

  2008cites this paper
• Impact of Angiogenesis Inhibition by Sunitinib on Tumor Distribution of Temozolomide

  2008cites this paper
• Isolation of coumarins and ferulate from the roots of Angelica purpuraefolia and the antitumor activity of khellactone

  2007influential citation
• Preclinical Pharmacokinetic and Pharmacodynamic Evaluation of Metronomic and Conventional Temozolomide Dosing Regimens

  2007cites this paper
• Anti-angiogenic therapy for osteosarcoma

  2007cites this paper
• Antitumor activity of 4-arylcoumarins from endophytic Streptomyces aureofaciens CMUAc130.

  2007cites this paper
• In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor.

  2007cites this paper
• Angiogenesis can be reduced without significant reduction of tumor growth.

  2007cites this paper
• Inhibition of expression of vascular endothelial growth factor and its receptors in pulmonary adenocarcinoma cell by TNP-470 in combination with gemcitabine

  2006cites this paper
• In vivo antitumor effects of bitter principles from the antlered form of fruiting bodies of Ganoderma lucidum

  2006cites this paper
• Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma.

  2006cites this paper
• Antitumor activity of the novel human cytokine AIMP1 in an in vivo tumor model.

  2006cites this paper
• Antioxidant, pro‐oxidant effect of the thiosemicarbazone derivative Schiff base (4‐(1‐phenylmethylcyclobutane‐3‐yl)‐2‐(2‐hydroxybenzylidenehydrazino) thiazole) and its metal complexes on rats

  2006cites this paper
• Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.

  2006cites this paper
• Synergistic Antitumor Effect of an Angiogenesis Inhibitor (TNP-470) and Tumor Necrosis Factor in Mice

  2006cites this paper
• Absence of the Angiogenesis Inhibitor TNP-470 Uptake of Temozolomide in a Rat Glioma Model in the Presence Updated Version

  2006cites this paper
• Dynamics of vascular normalization during anti-angiogenic therapy : implications for combination therapy

  2005cites this paper
• Antiangiogenesis: a possible treatment option for prostate cancer?

  2005cites this paper
• Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid Tumors

  2005cites this paper
• Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma

  2005cites this paper
• Inhibition of tumor angiogenesis during cisplatin chemotherapy for bladder cancer improves treatment outcome.

  2005cites this paper
• Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.

  2005cites this paper
• ImprovedTherapeutic Effectiveness by Combining Recombinant CXCChemokine Ligand 10 with Cisplatin in SolidTumors

  2005cites this paper
• Cytokine and Angiogenesis Inhibitors

  2005cites this paper
• Antiangiogenesis in prostate cancer

  2004cites this paper
• An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action

  2004cites this paper
• Antiangiogenic Chemotherapeutic Agents

  2004cites this paper
• Effect of cis-diammine dichloroplatinum on vascular endothelial growth factor expression in uterine cervical carcinoma.

  2004cites this paper
• Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

  2004cites this paper
• In vivo and in vitro studies on the anticancer activity of Copaifera multijuga hayne and its fractions

  2003influential citation
• Pharmacodynamic-Mediated Effects of the Angiogenesis Inhibitor SU5416 on the Tumor Disposition of Temozolomide in Subcutaneous and Intracerebral Glioma Xenograft Models

  2003cites this paper
• Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.

  2003cites this paper
• Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.

  2003cites this paper
• Concise stereocontrolled routes to fumagillol, fumagillin, and TNP-470.

  2003cites this paper
• Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.

  2003influential citation
• Annonaceous acetogenins from the leaves of Annona montana.

  2002cites this paper
• TNP-470 combined with nicardipine suppresses in vivo growth of PC-3, a human prostate cancer cell line.

  2002cites this paper
• Antitumor Effects Induced by the Combination of TNP-470 as an Angiogenesis Inhibitor and Lentinan as a Biological Response Modifier in a Rabbit Spontaneous Liver Metastasis Model

  2002cites this paper
• Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model

  2002cites this paper
• Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.

  2002cites this paper
• Targeting Vascular Endothelium with Antibodies

  2002cites this paper
• Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer

  2002cites this paper
• Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.

  2002cites this paper
• Short-term effects of TNP-470 in combination with cisplatin in the rat model of bladder cancer.

  2002cites this paper
• Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats

  2001cites this paper
• Cytotoxic alkaloids and a flavan from the bulbs of Crinum asiaticum var. japonicum.

  2001cites this paper
• Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.

  2001cites this paper
• Anti‐angiogenic Treatment for Peritoneal Dissemination of Pancreas Adenocarcinoma: A Study Using TNP‐470

  2001cites this paper
• The control of prostate-specific antigen expression and gene regulation by pharmacological agents.

  2001cites this paper
• Inhibition of hepatic metastasis in mice treated with cell-binding domain of human fibronectin and angiogenesis inhibitor TNP-470

  2001cites this paper
• The Role of the Microcirculation in the Treatment of Malignant Tumors: Facts and Fiction

  2000cites this paper
• TNP-470: an angiogenesis inhibitor in clinical development for cancer

  2000cites this paper
• [An angiogenesis inhibitor: TNP-470].

  2000cites this paper
• Angiogenesis Inhibitors

  2000cites this paper
• Angiogenesis and surgery: from mice to man.

  2000cites this paper
• ENHANCED ANTITUMOR EFFECTS BY COMBINATION OF TNP-470, ANGIOGENESIS INHIBITOR AND 5-FLUOROURACIL ON MOUSE SYNGENEIC SOLID CARCINOMA (NR-S1)

  2000cites this paper
• Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone.

  2000cites this paper
• Combination of Angiogenesis Inhibitor TNP-470 with Cytotoxic Drugs in Experimental Therapy of Nasopharyngeal Carcinoma

  2000cites this paper
• Understanding angiogenesis and its clinical applications.

  2000cites this paper
• Angiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci.

  2000cites this paper
• Synergistic effect of the angiogenesis inhibitor TNP-470 and tumor necrosis factor (TNF) on Bomirski Ab melanoma in hamsters.

  2000cites this paper
• Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo.

  2000cites this paper
• [Antitumor effect of the angiogenesis inhibitor, TNP470, on squamous cell carcinoma cells in head and neck cancer].

  2000cites this paper
• Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma

  1999cites this paper
• Time until initiation of tumor growth is an effective measure of the anti-angiogenic effect of TNP-470 on human glioblastoma in nude mice.

  1999cites this paper
• Antitumor effect of the angiogenesis inhibitor TNP-470 on human digestive organ malignancy

  1999cites this paper
• Anti-Tumor Effect of Angiogenesis Inhibitor TNP-470 on the Human Nasopharyngeal Carcinoma Cell Line NPC/HK1

  1999cites this paper
• Delay in administration of CDDP until completion of AGM-1470 treatment enhances antimetastatic and antitumor effects

  1999cites this paper
• Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor

  1999influential citation
• Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma

  1999cites this paper
• Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas.

  1999cites this paper
• Angiosuppression and Chemotherapy: Strategies Aimed at Their Integration in Cancer Patients

  1999cites this paper
• Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma.

  1999cites this paper
• Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

  1999cites this paper
• Angiocytotoxic therapy in human non-small cell lung cancer cell lines--advantage of combined effects of TNP-470 and SN-38.

  1998cites this paper